DULOXTA ® 60

duloxta samping-e

COMPOSITION
Each delayed-release capsule formulation contains enteric-coated pellets of Duloxetine hydrochloride
equivalent to 60 mg of Duloxetine that are designed to prevent degradation of the drug in the acidic
environment of the stomach.

 

 

INDICATIONS

  • Duloxetine is indicated for the treatment of depression.
  • Duloxetine is indicated for the treatment of diabetic neuropathic pain (DPNP).
  • Duloxetine is indicated for the treatment of generalized anxiety disorder (GAD). Duloxetine is effective in the
    prevention of relapse of GAD during 6 months of continuing therapy in patients who have shown initial
    treatment response.